ES | EN

Your shopping cart

Amount

Total (VAT incl.)

VAT (21%)
Total
You have not added any reports to the cart yet.
Request reports
If you prefer to place your order via e-mail
contact us at: digital@azierta.com

Safety Reports

Azierta is an European Consultancy with a long tradition and experience of writing top-quality Safety reports (PSUR/PBRER, ACO, RMP, DSURS, Signal Detection reports).

We are committed to patient safety helping our clients to meet the increasingly complex regulatory environment in pharmacovigilance.

What reports can you find?

PSUR / PBRER

The PBRER is a periodic assessment of the risk-benefit ratio of the medicinal product. The PBRER shall be submitted to the Health Authorities from marketing authorization, irrespective of the date of marketing. 

A periodic benefit risk evaluation report (PBRER) is necessary for all approved medicinal products (unless they are covered by the derogation given in Directive 2001/83, Article 107b.)

ACO

Addendum to the Clinical Overview (ACO) is an updated report of the module 2.5 of the registration dossier.

Is mandatory to submit and ACO in quinquennial renewals for medicinal products, and it is a critical discussion focused on the assessment of the current risk-benefit ratio of a medicinal product in order to guarantee that safety and efficacy are still positive.

RMP

The objective of a Risk Management Plan (RMP) is to determine the safety risk of medicinal products throughout post-authorization phase, and to define Risk Minimization activities  and to assess their effectiveness . The development of RMP involves to identify risks related to the use of medicinal products, taking into account potential risk and unknown safety information.

The submission is mandatory in registration dossier (module 1.8)

DSUR

DSUR is an annual safety report for Clinical Trials. This report evaluates the safety profile of the medicinal products in Clinical Trials, and the risk associated to the patients included in the study. DSUR must determine implemented or proposed actions to minimized identified risks.

This report is submitted annually to Health Authorities and ethics committees.

Signal Detection

Signal detection is defined as 'The act of looking for and/or identifying signals using event data from any source.'

To present it in a more simplified way, signal detection or signaling represents the detection of early warning signs throughout the lifecycle of medicinal products.

Leading innovation in pharma & health

100 professionals

Over 100 professionals

500 clients

Over 500 clients

9 year experience

9 years of experience

Innovation

Leading innovation

Client oriented

100% client oriented

DO YOU HAVE ANY DOUBTS?

We help you in everything you need. Contact us by filling out the form or book an appointment for a video call with one of our experts.

We use "cookies" to improve your experience on our site. Cookies enable us to tailor messages and display ads to your interests. They also help us understand how our site is being used. By continuing to use our site you consent to use our cookies.

We are at your complete disposal for any inquiry

Thank you for getting in touch! We will contact you as soon as possible to help you out
There has been an error while submitting your form, please try again, or call us at 912 77 10 76

How can we
help you?

    There was an error submitting your details, please try again.
    Azierta

    Your request has been submitted
    correctly

    Our team is working
    to get in contact you
    as soon as possible

    Thank you
    very much!